InvestorsHub Logo
Followers 145
Posts 27561
Boards Moderated 3
Alias Born 02/07/2004

Re: DrStockonomics post# 6044

Wednesday, 10/11/2017 1:57:22 PM

Wednesday, October 11, 2017 1:57:22 PM

Post# of 8449
Sure, read this:

- Kitov acquires an additional 27% ownership stake in TyrNovo and NT219, its oncology therapeutic candidate, in exchange for Kitov stock at a value of $2.50 per ADS.



From recent PR:
https://finance.yahoo.com/news/kitov-boosts-ownership-tyrnovo-oncology-122000438.html

Therefore it is only logical for KTOV to be worth
at least $2.50!